Cordavis Limited

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Cordavis Limited is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Cordavis Limited

Cordavis Limited is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by USTEKINUMAB-TTWE. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: plaque psoriasis, psoriatic arthritis, moderately severely, pyzchiva indicated, treatment adult, moderate severe, phototherapy systemic, crohn disease. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
USTEKINUMAB-TTWE 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — SUBCUTANEOUS 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Cordavis Limited

Brand nameGenericTypeRoute
PYZCHIVA USTEKINUMAB-TTWE HUMAN PRESCRIPTION DRUG SUBCUTANEOUS

Frequently asked questions

How many FDA drug products does Cordavis Limited make?
1 FDA drug label records name Cordavis Limited as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Cordavis Limited produce?
The most frequent active ingredients in this portfolio are USTEKINUMAB-TTWE.

Are Cordavis Limited products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.